Abstract
Background/Aims
A Helicobacter pylori (H. pylori) infection is the most common cause of chronic gastritis (CG), with approximately 50% of the world’s population infected. Long-term infection increases the risk of progression to gastric cancer. This study evaluated the histopathological changes in CG using the Updated Sydney System (USS) to estimate the prevalence and correlation of H. pylori gastritis with other histological variables.
Methods
This research was a prospective observational study conducted in the Department of Pathology of a tertiary care teaching hospital in Central India. The study was conducted between Feb 2017 to April 2018. Two antral biopsies were taken per patient, one for a Rapid Urease Test and the second for routine histopathology. All samples were analyzed according to the USS.
Results
CG was found in 83.84% of total dyspeptic patients. The most common age group was 31–40 years, with a male preponderance. Of 109 gastric antral biopsies with histopathological evidence of chronic gastritis, neutrophilic activity, intestinal metaplasia, atrophy, and lymphoid aggregates were present in 50 (45.87%), 10 (9.2%), 23 (21.10%), and 11(10.09%) cases, respectively. The prevalence of H. pylori was 46.78%, and its association with the degree of chronic inflammation and intestinal metaplasia was statistically significant.
Chronic gastritis (CG) is the chronic inflammation of the gastric mucosa associated with varying degrees of superficial and glandular epithelial damage.1 Helicobacter pylori (H. pylori) is a gram-negative bacterium and the most common cause of CG. Approximately 50% of the world’s population is infected with H. pylori.2 The percentage is higher in developing countries and more in men than women.3 Long-term infection increases the risk of progression to gastric cancer. Gastric carcinoma is the second most common malignancy worldwide.4,5 An accurate diagnosis of H. pylori-associated gastritis is crucial in clinical practice because H. pylori-associated gastritis indicates the early phase of gastric carcinogenesis.6-8 H. pylori infection is a treatable condition. Therefore, early detection and eradication improve the quality of life with a decreased severity of dyspeptic symptoms and a decrease in the risk of gastric malignancy. The Updated Sydney System (USS) for grading and classifying CG was conceived to provide a unified and standardized application to interpret antral biopsies.9 In the USS, the following five histological parameters are graded as mild, moderate, or severe: chronic inflammation, activity (neutrophilic infiltration), atrophy, intestinal metaplasia, and H. pylori density.9 Few studies have examined H. pylori gastritis and its association with histomorphological features by the USS in central India. Therefore, this study evaluated the histopathological changes in chronic gastritis using the USS to determine the prevalence and correlation of H. pylori gastritis with other histological variables. These results offer new insights and details regarding H. pylori gastritis-associated histopathological features and its prevalence in central India.
This research was a prospective observational study conducted in the Department of Pathology of a tertiary care teaching hospital in Central India. The study was conducted between February 2017 to April 2018. The study population included all dyspeptic patients aged from 16 to 72 years who attended the gastroenterology outpatient department except the patients with a present or past history of GI malignancy, gastric surgery, taking long-term non-steroidal anti-inflammatory drugs, alcohol, and acid-suppressive therapy. Written informed consent was obtained from all subjects before enrolment in the study. The institutional ethics committee approved the study protocol.
Demographic data, history of smoking, and blood group of each recruited subject were collected prospectively and entered in a predesigned questionnaire.
Patients with dyspepsia were subjected to endoscopy, and two antral biopsies were taken from each patient. One was subjected to a Rapid Urease Test (RUT) (RUT dry test of Gastro cure systems, Kolkata, W.B. India) and the other for routine histopathological analysis. The special stain Giemsa was also performed to confirm the presence of H. pylori in each biopsy. The histomorphological features were studied in detail in hematoxylin- eosin-stained sections according to the USS, and each variable was graded semi-quantitatively and analyzed with demographic data of patients.9 For blood group analysis, venous blood samples were collected in an ethylenediaminetetraacetic acid vial, and forward and reverse grouping were performed.
Statistical analysis was done using SPSS version 26 software (IBM Co.). The association between the histological findings and H. pylori positivity was assessed, and the statistical significance was calculated using a Fisher’s exact test and Chi-square test. The correlations among different histological variables were calculated using the Pearson’s correlation coefficient; a p-value <0.05 was considered significant.
One hundred and thirty gastric antral biopsies from the patients who presented with the symptoms of dyspepsia were obtained. Of the 130 patients, 109 cases showed histopathological evidence of chronic gastritis, which was included in the study. The age range in this study was 16 to 72 years. The most common age group was 31–40 years, followed by 41–50 years. The subjects included 63 males and 46 females with an M:F ratio of 1.36:1.
Of 109 gastric antral biopsies with histopathological evidence of chronic gastritis, 50 (45.87%), 10 (9.2%), 23 (21.10%), and 11 (10.09%) cases showed neutrophilic activity, intestinal metaplasia, atrophy, and lymphoid aggregates, respectively. H. pylori was detected in 51 (46.78%) cases of CG (Figs. 1, 2). Table 1 lists the association of H. pylori with the degree of other variables of the USS. A significant association was observed between the degree of chronic inflammation and intestinal metaplasia with H. pylori (p-value<0.05).
The RUT results were available in 103 cases but in six. Of these 103 cases, H. pylori was positive in 49 cases, whereas the test was negative in 54 cases. Six cases for which RUT was unavailable, two cases showed the presence of H. pylori on histological examination (Table 2). The RUT results were compared with the histopathological detection of H. pylori. Of 49 histopathologically proven H. pylori-positive cases, 39 were positive by RUT, and of 54 H. pylori-negative cases on histopathology, six cases were positive on RUT. Thus, the sensitivity and specificity of RUT in this study were 79.59% and 88.89%, respectively. The positive and negative predictive values of the test were 86.67% and 82.67%, respectively. Table 3 lists the association between the degree of the different variables of the USS in CG.
The correlations between the different variables of the Sydney System calculated, and statistically significant correlations were found between chronic inflammation and neutrophilic activity (r=0.458, p-value<0.001), chronic inflammation and lymphoid hyperplasia (r=0.251, p-value=0.008), neutrophilic activity and atrophy (r=0.312, p-value=0.001), and atrophy and intestinal metaplasia (r=0.245, p-value= 0.01) (Table 4).
Association of H. pylori with different ABO blood groups of the patients of CG was observed. A statistically significant association with the A+ blood group (p-value=0.001), followed by the AB+ blood group, was noted. An association was observed between smoking and H. pylori positivity, but it was not significant.
Chronic gastritis was the major cause of dyspepsia in the present study, comprising 83.84% (109/130), similar to Sharma et al.10, who reported an 89% prevalence in Jammu and Kashmir. A lower prevalence of histological gastritis was reported in a study in Thailand (58.7%) and Malaysia (78.2%) among total dyspeptic patients.11,12 The common age group of CG in this study was 31–40 and 41–50 years, similar to Sharma et al.10 and Mujawar et al.13, whereas Pruthi et al.14 reported 61–70 and 51–60 years to the most common age group. In the present study, CG showed a male predominance, similar to other studies.13,15-17 The prevalence of H. pylori in the present study (46.78%) was comparable to Garg et al.18 (43.67%) from Ludhiana, whereas studies from other parts of India reported a higher prevalence of H. pylori (46– 67%).15,16,19,20 The prevalences of H. pylori from Pakistan,21 Brazil,22 Thailand,11 Malaysia,12 and Kosovo23 were reported to be 62.5%, 58,5%, 48.2%, 6.8%, and 23.38%, respectively. This variation was attributed mainly to a varied geographical area, socioeconomic status, and sanitation standards.
RUT in biopsy specimens is also a good choice for rapid detection of the organism. In the present study, the sensitivity and specificity of RUT were similar to Dandin et al.19 Pruthi et al.14, reported very low specificity (37.5%) but relatively comparable sensitivity (62.5%) with the present findings (79.59%). The reason for 10 false negative tests in the present study could be attributed to low bacterial density. In contrast, six false positive results could be better explained by the presence of other urease-producing bacteria like Proteus mirabilis and Klebsiella pneumonie.
Using the USS of CG, chronic inflammation was present in 100% of cases, with 53.2%, 40.3%, and 6.42% mild, moderate, and severe inflammation, respectively. Sharma et al.10, Garg et al.18, and Manxhuka-Kerliu et al.24, also found that the majority of cases had mild inflammation, similar to the present study. In contrast, Pruthi et al.14 and Türkay et al.25 reported the moderate grade of chronic inflammation to be the prevailing grade in CG. Sharma et al.10, Pruthi et al.14, and Türkay et al.25 reported that H. pylori colonization increased as the degree of chronic inflammation agreement with the present study. A significant association was observed between H. pylori and a moderate grade of inflammation.
Neutrophilic infiltration (activity) was present in 50% of cases, similar to Shafii et al.26 (49.26%), whereas Sharma et al.10 and Garg et al.18 observed 39.33% and 33.3%, respectively. The association between H. pylori and neutrophilic activity was significant in various studies similar to the present study.13,15,17,18,21 Pruthi et al.14 and Türkay et al.25 reported an increase in H. pylori positivity as the degree of activity increased, but the present study observed no statistically significant association between neutrophilic activity and H. pylori. This might be because of variation in the prevalence of H. pylori in antral biopsies despite multiple site biopsies.
A higher prevalence (9.2%) of intestinal metaplasia was observed in the present study, compared to Sharma et al.10 (7.87%), Atisook et al.22 (8.2%), and Garg et al.18 (7%). A mild degree of intestinal metaplasia was significantly related to H. pylori in the present study, similar to Türkay et al.25 and Shafii et al.26 On the other hand, Nai et al.8, Sharma et al.10, and Garg et al.18 observed no significant correlation.
Atrophy was observed in 23 (21.10%) of total CG cases. The results were comparable to Shafii et al.26 (17.65%), while lower values were reported by Sharma et al.10 (12.36%), Atisook et al.22 (11.6%), Garg et al.18 (12.3%), and Manxhuka-Kerliu et al.24 (14.94%). Similar to the present study, a non-significant association of H. pylori with atrophy was observed in many studies.13-15,18 This could be explained by the bacteria remaining and multiplying on epithelial cells. Thus, atrophy is an unfavorable factor for their growth.
Only 11 (10.09%) cases of lymphoid aggregates and follicles were found. Out of these 11 cases, 63.6% showed H. pylori positivity. On the other hand, Sharma et al.10 and Shafii et al.26 reported lymphoid follicles and aggregates in 29.2% and 45.58% of cases, respectively, with H. pylori positivity observed in 80.64% (50 out of 62) and 76.92% (20 out of 26 cases) of those cases, respectively. The association of H. pylori colonization with lymphoid aggregates was not significant in the present study compared to these studies. Nevertheless, there was a very high association between lymphoid follicle formation and CG in the present study.
Among the 51 cases of H. pylori, the most frequent histological finding was chronic inflammation (100%), followed by lymphoid aggregates (63.6%), and the least was neutrophilic activity (56%). Sharma et al.10 and Hemalata et al.27 also reported chronic inflammation in 100% of H. pylori-positive cases and neutrophilic activity in 66.67% and 80% of cases, respectively. In contrast, Nai et al.8, reported more neutrophilic activity in H. pylori-negative cases (72.3%) than in H. pylori-positive cases (53%). Sharma et al.10 and Hemalata et al.27 reported a lower rate of intestinal metaplasia: 7.87% and 8%, respectively. Lymphoid aggregates were present in only 63.6% of H. pylori- positive cases in the present study, whereas Sharma et al.10 and Shafii et al.26 observed them in 80.64% and 76.92% of cases, respectively.
The correlation among various histological parameters of the USS of CG was calculated and significant correlations were observed between chronic inflammation and neutrophilic activity (r=0.458, p-value<0.001), chronic inflammation and lymphoid hyperplasia (r=0.251, p-value=0.008), and atrophy and intestinal metaplasia (r=0.245, p-value=0.01), similar to Garg et al.18 On the other hand, the present study observed a statistically significant correlation between neutrophilic activity and atrophy (r=0.312, p-value=0.001) in contrast to Garg et al.18
CG patients with different ABO blood groups showed a maximum association of H. pylori in A+ patients, followed by AB+. By contrast, Mattos et al.28 and Baqir et al.29 found H. pylori to be more prevalent in the “O” blood group than other blood groups. This discrepancy between the present study and others might be due to the low prevalence of H. pylori and regional variability.
The major limitations of this study were the small sample size, no topographical study, using only an antral biopsy, and no special stains (e.g., alcian blue-periodic acid Schiff) to detect the incomplete intestinal metaplasia. Therefore, an assessment of multiple gastric biopsy specimens is necessary to provide a global picture of H. pylori infection in the stomach. On the other hand, maximum prevalence has been demonstrated through the body greater curvature. In the present study, the author has done two antral biopsies to observe the histopathological changes because of a H.pylori infection and found a smaller prevalence of H.pylori infection than biopsies on the sites of body greater curvature. The histological findings other than the USS associated with H. pylori infection were also not evaluated. The strength of this study was interobserver reproducibility because at least two pathologists studied each biopsy. Nevertheless, studies with a larger sample size and biopsies from different sites of the stomach should be conducted to validate the importance of the USS in an Indian scenario.
H. pylori was significantly associated with the degree of chronic inflammation and intestinal metaplasia. The presence of intestinal metaplasia is a significant risk factor for progression to gastric cancer. This paper suggests a vigorous search for H. pylori if chronic inflammation and intestinal metaplasia are observed in antral gastric biopsies. The USS is extremely useful for analyzing gastric biopsies, and it offers a standardized and unified approach for the diagnosis of H. pylori-associated gastritis.
REFERENCES
1. Cheli R, Testino G, Giacosa A, Cornaggia M. 1995; Chronic gastritis: its clinical and physiopathological meaning. J Clin Gastroenterol. 21:193–197. DOI: 10.1097/00004836-199510000-00005. PMID: 8648051.
2. Feldman M, Lee EL. Feldman M, editor. 2016. Gastritis. Sleisenger and Fordtran’s gastrointestinal and liver disease. 10th ed. Elsevier Saunders publishers;p. 868.
3. Dixon MF, Genta RM, Yardley JH, Correa P. 1996; Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 20:1161–1181. DOI: 10.1097/00000478-199610000-00001. PMID: 8827022.
4. Satoskar A, Vora IM. 1994; Incidence of Helicobacter pylori associated gastritis in the urban population from India. Trop Geogr Med. 46:167–168. PMID: 7941008.
5. Maitra TN, Ghosh S. 1991; Gastritis and Helicobacter (Campylobacter) pylori--merely one more piece in the jigsaw puzzle or the final answer? Indian J Pathol Microbiol. 34:67–79. PMID: 1794913.
6. Yakoob MY, Hussainy AS. 2010; Chronic gastritis and Helicobacter pylori: a histopathological study of gastric mucosal biopsies. J Coll Physicians Surg Pak. 20:773–775. PMID: 21078257.
7. Abu-Ahmad NM, Odeh A, Sallal AKJ. 2011; Prevalence of Helicobacter pylori gastritis at the north of Jordan. Jordan J Biol Sci. 4:71–76.
8. Nai GA, Parizi AC, Barbosa RL. 2007; Association between Helicobacter pylori concentration and the combining frequency of histopathological findings in gastric biopsies specimens. Arq Gastroenterol. 44:240–243. DOI: 10.1590/S0004-28032007000300012. PMID: 18060279.
9. Warren JR, Marshall B. 1983; Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1:1273–1275. DOI: 10.1016/S0140-6736(83)92719-8. PMID: 6134060.
10. Sharma P, Kaul KK, Mahajan M, Chandail VS, Goswami K, Gupta P. 2015; Histopathological changes in gastric mucosal biopsies in chronic gastritis and correlation of pathological features with Helicobacter pylori infection. Trop J Pathol Microbiol. 1:8–15. DOI: 10.17511/jopm.2015.i01.03.
11. The EUROGAST Study Group. 1993; An international association between Helicobacter pylori infection and gastric cancer. Lancet. 341:1359–1362. DOI: 10.1016/0140-6736(93)90938-D. PMID: 8098787.
12. Pinto-Santini D, Salama NR. 2005; The biology of Helicobacter pylori infection, a major risk factor for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 14:1853–1858. DOI: 10.1158/1055-9965.EPI-04-0784. PMID: 16103425.
13. Mujawar P, Nikumbh DB, Suryawanshi KH, Pagare PS, Surana A. 2015; Helicobacter pylori associated gastritis in Northern Maharashtra, India: A histopathological study of gastric mucosal biopsies. J Clin Diagn Res. 9:EC04–EC06. DOI: 10.7860/JCDR/2015/13306.6040. PMID: 26266125. PMCID: PMC4525514.
14. Pruthi S, Nirupama M, Chakraborti S. 2014; Evaluation of gastric biopsies in chronic gastritis: grading of inflammation by visual analogue scale. Med J DY Patil Univ. 7:463–467. DOI: 10.4103/0975-2870.135268.
15. Godkhindi VM, Meshram DP, Deshpande SA, Kadam PN, Chavan YH. 2013; The histopathological study of various gastro-duodenal lesions and their association with Helicobacter pylori infection. ISOR J Dental and Medic Sci. 4:51–55. DOI: 10.9790/0853-0435155.
16. Santacroce L, Cagiano R, Del Prete R, et al. 2008; Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight. Clin Ter. 159:457–462. PMID: 19169609.
17. Hui PK, Chan WY, Cheung PS, Chan JK, Ng CS. 1992; Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol. 23:548–556. DOI: 10.1016/0046-8177(92)90132-M. PMID: 1568749.
18. Garg B, Sandhu V, Sood N, Sood A, Malhotra V. 2012; Histopathological analysis of chronic gastritis and correlation of pathological features with each other and with endoscopic findings. Pol J Pathol. 63:172–178. DOI: 10.5114/pjp.2012.31501. PMID: 23161233.
19. Dandin AS, Pawale J, Athanikar S. 2012; Helicobacter pylori associated gastritis. J Clin Diagn Res. 6:211–214. DOI: 10.33545/pathol.2019.v2.i2d.106. PMID: 26266125. PMCID: PMC4525514.
20. Chen XY, Liu WZ, Shi Y, Zhang DZ, Xiao SD, Tytgat GN. 2002; Helicobacter pylori associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa. J Clin Pathol. 55:133–137. DOI: 10.1136/jcp.55.2.133. PMID: 11865009. PMCID: PMC1769586.
21. Kumar A, Bansal R, Pathak VP, Kishore S, Karya PK. 2006; Histopathological changes in gastric mucosa colonized by H. pylori. Indian J Pathol Microbiol. 49:352–356. PMID: 17001883.
22. Atisook K, Kachinthorn U, Luengrojanakul P, Tanwandee T, Pakdirat P, Puapairoj A. 2003; Histology of gastritis and Helicobacter pylori infection in Thailand: a nationwide study of 3776 cases. Helicobacter. 8:132–141. DOI: 10.1046/j.1523-5378.2003.00134.x. PMID: 12662381.
23. Yeh LY, Raj M, Hassan S, et al. 2009; Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori. Indian J Gastroenterol. 28:49–52. DOI: 10.1007/s12664-009-0017-0. PMID: 19696988.
24. Manxhuka-Kerliu S, Telaku S, Devolli-Disha E, et al. 2009; Helicobacter pylori gastritis updated Sydney classification applied in our material. Prilozi. 30:45–60. PMID: 19736530.
25. Türkay C, Erbayrak M, Bavbek N, Yenıdünya S, Eraslan E, Kasapoğlu B. 2011; Helicobacter pylori and histopathological findings in patients with dyspepsia. Turk J Gastroenterol. 22:122–127. DOI: 10.4318/tjg.2011.0179. PMID: 21796546.
26. Shafii M, Nikzad SE, Kasiri H, Naghipour M. 2008; Histopathological evaluation of chronic gastritis with and without Helicobacter pylori colonization: a study from Iran. Malays J Pathol. 30:27–30. PMID: 19108408.
27. Hemalata M, Sahadev R, Nanda N, Preethan KN, Suguna BV. 2013; Prevalence of Helicobacter pylori infection and histomorphologic spectrum in endoscopic biopsies. International J Biomedical Research. 4:608–614. DOI: 10.7439/ijbr.v4i11.403.
28. Mattos DE, Cintra JR, Mattos CC, et al. 2010; ABO blood groups and Helicobacter pylori cagA infection: evidence of an association. J Venom Anim Toxins Incl Trop Dis. 16:87–95. DOI: 10.1590/S1678-91992010005000004.
29. Baqir GK, AI-Sulami A, Hamadi SS. 2016; Relatioship between ABO Blood Groups and Helicobacter Pylori Infection among Patients with dyspepsia. J Virol Microbiol. 2016:688370.
Table 1
Histological variables | H. pylori positive | H. pylori negative | Total | p-value* |
---|---|---|---|---|
Chronic inflammation, n=109 | 0.037* | |||
Mild | 22 | 36 | 58 | |
Moderate | 23 | 21 | 44 | |
Severe | 6 | 1 | 7 | |
Neutrophilic activity, n=50 | 0.191 | |||
Nil | 23 | 36 | 59 | |
Mild | 19 | 14 | 33 | |
Moderate | 9 | 7 | 16 | |
Severe | 0 | 1 | 1 | |
Atrophy, n=23 | 0.445 | |||
Nil | 37 | 49 | 86 | |
Mild | 7 | 5 | 12 | |
Moderate | 6 | 3 | 9 | |
Severe | 1 | 1 | 2 | |
Intestinal metaplasia, n=10 | 0.034* | |||
Nil | 45 | 54 | 99 | |
Mild | 4 | 0 | 4 | |
Moderate | 1 | 4 | 5 | |
Severe | 1 | 0 | 1 |